speb/financial-data huggingface dataset:
MATD.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 464700.099
P/B ratio: 0.01933229741029641
Pays dividend: no
Net asset value (USD): 24037500
Net cash (USD): 1653750
Net cash to market cap %: 355.8746820925467
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MATD.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Energy | Industry: Oil & Gas E&P
Lynch category: Cyclical (confidence: High)
Market cap (USD): 27630816.216216218
P/B ratio: 0.00987253237731039
Pays dividend: no
Net asset value (USD): 25443243.243243244
Net cash (USD): 377027.02702702675
Net cash to market cap %: 1.364516430049409
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 13157293.274074074
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 7763263.076923078
Net income (USD): -536669.93006993
P/B ratio: 0.7006474200046793
Pays dividend: no
Net asset value (USD): 11080127.972027972
Net cash (USD): -1391340.5594405595
Net cash to market cap %: -17.922110144333907
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.3239254567176673 (Distress Zone)
Piotroski F-score: 3 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 7763263.076923078
Net income (USD): -558400
P/B ratio: 0.7296043339345749
Pays dividend: no
Net asset value (USD): 10494502.797202798
Net cash (USD): -604453.846153846
Net cash to market cap %: -7.7860796441464615
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.461446239160908 (Distress Zone)
Piotroski F-score: 4 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 8103259.999999999
Net income (USD): -459667.1532846715
P/B ratio: 0.7589810951156651
Pays dividend: no
Net asset value (USD): 10561588.321167883
Net cash (USD): -1039710.2189781023
Net cash to market cap %: -12.830764642601897
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.554216094405981 (Distress Zone)
Piotroski F-score: 3 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 20765332.460431658
Net income (USD): -437341.00719424465
P/B ratio: 2.0204270055794504
Pays dividend: no
Net asset value (USD): 10162408.633093527
Net cash (USD): -1428447.4820143885
Net cash to market cap %: -6.87900126201348
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.1326738456738674 (Grey Zone)
Piotroski F-score: 2 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 17827172
Net income (USD): -775943.795620438
P/B ratio: 1.4803956607708595
Pays dividend: no
Net asset value (USD): 11957085.401459852
Net cash (USD): 87346.71532846731
Net cash to market cap %: 0.48996394564694457
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.205675944584341 (Safe Zone)
Piotroski F-score: 4 (Weak)
MAX.V — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 8984999.28057554
Net income (USD): -594248.201438849
P/B ratio: 1.1793484269994752
Pays dividend: no
Net asset value (USD): 11429461.870503599
Net cash (USD): -855443.8848920863
Net cash to market cap %: -9.520800816773022
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1.0265114330380047 (Distress Zone)
Piotroski F-score: 3 (Weak)
MAXHEALTH.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category:  (confidence: Medium)
Market cap (USD): 4433823016.588948
Pays dividend: no
Net cash (USD): 35456943.162336804
Net cash to market cap %: 0.7996923429211372
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MAXHEALTH.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 5196007522.466261
Net income (USD): 134410475.03045067
P/E ratio: 38.65775730120071
P/B ratio: 5.757298549507867
Pays dividend: no
Net asset value (USD): 285516443.361754
Net cash (USD): -160527405.60292327
Net cash to market cap %: -3.0894375134916987
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 10.570541936160769 (Safe Zone)
Piotroski F-score: 4 (Weak)
MAXHEALTH.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 9528005323.476608
Net income (USD): 126830555.22244874
EPS growth %: -5.639381756730423
Revenue growth %: 16.449171884986335
Smoothed growth %: -5.639381756730423
P/E ratio: 75.12389508005695
P/B ratio: 9.449656688931373
Pays dividend: no
Net asset value (USD): 338831994.2439141
Net cash (USD): -313206619.49874085
Net cash to market cap %: -3.2872212899274182
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 14.369362267479808 (Safe Zone)
Piotroski F-score: 4 (Weak)
MAXHEALTH.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12422402401.457113
Net income (USD): 125775075.98784193
EPS growth %: -0.8321963368808031
Revenue growth %: 26.880070572028053
EPS 2-year CAGR %: -3.2656458982688985
Smoothed growth %: -0.8321963368808031
P/E ratio: 98.76680498016893
P/B ratio: 11.327438728184502
Pays dividend: no
Net asset value (USD): 391114098.66729015
Net cash (USD): -604620060.7902734
Net cash to market cap %: -4.8671749734926735
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 11.994706894437414 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MAXHEALTH.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 11143414732.344213
Net income (USD): 152862441.71259007
EPS growth %: 21.536354092416957
Revenue growth %: 7.904424214360279
EPS 2-year CAGR %: 9.783848085991863
Smoothed growth %: 9.783848085991863
P/E ratio: 0.6847935189884967
P/B ratio: 8.660812434190493
PEG ratio: 0.06999224773010915
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 502265790.58923274
Net cash (USD): -616350148.3679525
Net cash to market cap %: -5.53107071012058
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 10.90679569921569 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MBC — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MBC — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 966283654.5
Net income (USD): 155400000
P/E ratio: 6.218041534749035
P/B ratio: 0.9574748855529132
Pays dividend: no
Net asset value (USD): -264800000
Net cash (USD): -1419100000
Net cash to market cap %: -146.8616377179958
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.7995478941663614 (Grey Zone)
Piotroski F-score: 4 (Weak)
MBC — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1900571161.5
Net income (USD): 182000000
EPS growth %: 17.117117117117118
Revenue growth %: -16.76995878491833
Smoothed growth %: 17.117117117117118
P/E ratio: 10.442698689560439
P/B ratio: 1.5920348144580332
PEG ratio: 0.6100734497585308
Pays dividend: no
Net asset value (USD): -66800000
Net cash (USD): -1039200000
Net cash to market cap %: -54.67829992641925
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.4161855769651543 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MBC — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1869854859.8999999
Net income (USD): 125900000
EPS growth %: -30.824175824175825
Revenue growth %: -0.9463722397476341
EPS 2-year CAGR %: -9.99070547063986
Smoothed growth %: -30.824175824175825
P/E ratio: 14.85190516203336
P/B ratio: 1.4442379392137172
Pays dividend: no
Net asset value (USD): -402400000
Net cash (USD): -1514500000
Net cash to market cap %: -80.99559128781769
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.633897416645505 (Grey Zone)
Piotroski F-score: 4 (Weak)
MBC — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1412949873.6
Net income (USD): 26700000
EPS growth %: -78.79269261318507
Revenue growth %: 1.2701821952303363
EPS 2-year CAGR %: -61.69813363512206
Smoothed growth %: -78.79269261318507
P/E ratio: 52.91947092134831
P/B ratio: 1.0508328674698795
Pays dividend: no
Net asset value (USD): -330600000
Net cash (USD): -1572500000
Net cash to market cap %: -111.29198773297517
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.2289821212171073 (Grey Zone)
Piotroski F-score: 5 (Neutral)
MBINN — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 58239000
Pays dividend: no
Net asset value (USD): 1963010000
Net cash (USD): -16114219000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 37981000
Pays dividend: no
Net asset value (USD): 1983581000
Net cash (USD): -16307868000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 54701000
Pays dividend: no
Net asset value (USD): 2004264000
Net cash (USD): -16529648000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 4 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 67849000
Pays dividend: no
Net asset value (USD): 2055225000
Net cash (USD): -16954462000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
MBINN — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Net income (USD): 67732000
EPS growth %: 16.30007383368533
Revenue growth %: 19.967468692062223
Smoothed growth %: 16.30007383368533
P/E ratio: 4.252821670428895
PEG ratio: 0.2609081231055603
Dividend yield: 0.07
Pays dividend: yes
Net asset value (USD): 2092713000
Net cash (USD): -17906753000
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MBUU — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category:  (confidence: Low)
Market cap (USD): 762113561.21
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MBUU — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category:  (confidence: Low)
Market cap (USD): 738156371.19
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MBUU — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 602464417.88
Net income (USD): 13173000
P/E ratio: 11.433698054353602
P/B ratio: 1.1632024379073862
Pays dividend: no
Net asset value (USD): 291668000
Net cash (USD): -202117000
Net cash to market cap %: -33.54837132311074
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.9051394590386272 (Grey Zone)
Piotroski F-score: 4 (Weak)
MBUU — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 615424864.9399999
Net income (USD): 4793000
P/E ratio: 34.25497411443838
P/B ratio: 1.1838895663414981
Pays dividend: no
Net asset value (USD): 295521000
Net cash (USD): -177743000
Net cash to market cap %: -28.88134850016644
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.0950426236968505 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MBUU — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category: Speculative (confidence: Low)
Market cap (USD): 637221980.45
Net income (USD): -702000
P/E ratio: 36.9104483578545
P/B ratio: 1.2239510829250118
Pays dividend: no
Net asset value (USD): 298076000
Net cash (USD): -190882000
Net cash to market cap %: -29.955338305373736
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.930059539594736 (Grey Zone)
Piotroski F-score: 3 (Weak)
MBUU — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category: Speculative (confidence: Low)
Market cap (USD): 553960926.61
Net income (USD): -2462000
P/E ratio: 37.42473494189974
P/B ratio: 1.1095462288991085
Pays dividend: no
Net asset value (USD): 278401000
Net cash (USD): -188228000
Net cash to market cap %: -33.97856977961848
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.8540060100009494 (Grey Zone)
Piotroski F-score: 5 (Neutral)
MBUU — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Recreational Vehicles
Lynch category: Turnaround (confidence: High)
Market cap (USD): 543946048
Net income (USD): -2415000
EPS growth %: -118.33295376907311
Revenue growth %: 3.077030726574595
Smoothed growth %: -118.33295376907311
P/B ratio: 0.9758340303337635
Pays dividend: no
Net asset value (USD): 126005000
Net cash (USD): -435037000
Net cash to market cap %: -79.97796869736611
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.6542147314991311 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MBVI — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Shell Companies
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): -20258
Net cash (USD): -279745
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MBVI — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 1070544
Pays dividend: no
Net asset value (USD): 330901452
Net cash (USD): -15704635
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
MBVI — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 438581248
Net income (USD): 2893630
P/E ratio: 29.955885859629603
P/B ratio: 1.0290212910759828
Pays dividend: no
Net asset value (USD): 336946381
Net cash (USD): -15978450
Net cash to market cap %: -3.643213218272387
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 15.627108074504827 (Safe Zone)
Piotroski F-score: 4 (Weak)
MBX — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Net income (USD): -26135000
Pays dividend: no
Net asset value (USD): -42605000
Net cash (USD): -45239000
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MBX — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Net income (USD): -32563000
Pays dividend: no
Net asset value (USD): -72468000
Net cash (USD): -75972000
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 5 (Neutral)
MBX — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 877222588.48
Net income (USD): -61922000
P/B ratio: 3.407457168915717
Pays dividend: no
Net asset value (USD): 257442000
Net cash (USD): 251056000
Net cash to market cap %: 28.619418069821386
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 47.03748614455072 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MBX — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1501226285.44
Net income (USD): -86971000
P/B ratio: 4.065906743187721
Pays dividend: no
Net asset value (USD): 369223000
Net cash (USD): 357784000
Net cash to market cap %: 23.83278280363548
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 56.059687811636934 (Safe Zone)
Piotroski F-score: 4 (Weak)
MBX.TO — Peter Lynch category analysis (annual, as of 2021-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 67676350.21875
Pays dividend: no
Net cash (USD): 7801806.25
Net cash to market cap %: 11.528113181018556
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MBX.TO — Peter Lynch category analysis (annual, as of 2022-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 51186561.72262774
Net income (USD): 1305612.4087591239
P/E ratio: 39.20502086164784
P/B ratio: 2.811923480235803
Pays dividend: no
Net asset value (USD): 17109735.03649635
Net cash (USD): 3855134.3065693425
Net cash to market cap %: 7.531535967310589
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 5.120373098985923 (Safe Zone)
Piotroski F-score: 4 (Weak)
MBX.TO — Peter Lynch category analysis (annual, as of 2023-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 31574339.525925923
Net income (USD): -29246.666666666664
EPS growth %: -102.24007266402005
Revenue growth %: -12.144959019189635
Smoothed growth %: -102.24007266402005
P/B ratio: 1.7310150810451401
Pays dividend: no
Net asset value (USD): 14963754.814814813
Net cash (USD): 428111.11111111194
Net cash to market cap %: 1.3558830288740853
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 1.6837430725226112 (Distress Zone)
Piotroski F-score: 1 (Weak)
MBX.TO — Peter Lynch category analysis (annual, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 34629920.770370364
Net income (USD): 2607540
Revenue growth %: 53.76622728640099
EPS 2-year CAGR %: 41.321537972257886
Smoothed growth %: 41.321537972257886
P/E ratio: 13.28068630600887
P/B ratio: 1.6521075003707049
PEG ratio: 0.32139864481629765
Pays dividend: no
Net asset value (USD): 17835763.7037037
Net cash (USD): 2343703.7037037034
Net cash to market cap %: 6.767857539278562
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 3.296723146373809 (Safe Zone)
Piotroski F-score: 9 (Strong)
MBX.TO — Peter Lynch category analysis (annual, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 26708857.64028777
Net income (USD): -1615692.0863309354
EPS growth %: -161.96231261384045
Revenue growth %: -28.918523575821446
Smoothed growth %: -161.96231261384045
P/B ratio: 1.3360416016645158
Pays dividend: no
Net asset value (USD): 17307049.64028777
Net cash (USD): 1791632.3741007186
Net cash to market cap %: 6.708008250409825
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 2.0061194340152673 (Grey Zone)
Piotroski F-score: 3 (Weak)
MCA.AX — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Defensive | Industry: Farm Products
Lynch category: Asset Play (confidence: Low)
Market cap (USD): 23491003.92156863
P/E ratio: 34.96732026143791
P/B ratio: 2.6282294032440565
Pays dividend: no
Net asset value (USD): 61861468.62745098
Net cash (USD): -40370762.74509804
Net cash to market cap %: -171.85626838208904
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MCK — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Medical Distribution
Lynch category:  (confidence: Medium)
Market cap (USD): 35099907951
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MCK — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Medical Distribution
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 41061506726.4
Net income (USD): 3722000000
P/E ratio: 11.032108201612036
Pays dividend: no
Net asset value (USD): -14081000000
Net cash (USD): -59132000000
Net cash to market cap %: -144.00835408697213
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.274522115436962 (Safe Zone)
Piotroski F-score: 4 (Weak)
MCK — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Medical Distribution
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 62249066239.05
Net income (USD): 3160000000
EPS growth %: -15.09940891993552
Revenue growth %: 11.651145057478741
Smoothed growth %: -15.09940891993552
P/E ratio: 19.699071594636077
Pays dividend: no
Net asset value (USD): -14213000000
Net cash (USD): -64459000000
Net cash to market cap %: -103.5501476479396
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.558835366162118 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MCK — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Distribution
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 78395258052
Net income (USD): 3481000000
EPS growth %: 10.158227848101266
Revenue growth %: 16.21616372822875
EPS 2-year CAGR %: -3.291682588123701
Smoothed growth %: 10.158227848101266
P/E ratio: 22.520901480034475
Pays dividend: no
Net asset value (USD): -13560000000
Net cash (USD): -71143000000
Net cash to market cap %: -90.74911132100677
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.836919107000019 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MCK — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Distribution
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 98450677760
Net income (USD): 5099000000
EPS growth %: 46.480896294168346
Revenue growth %: 12.360082550946801
EPS 2-year CAGR %: 27.02785501364293
Smoothed growth %: 27.02785501364293
P/E ratio: 22.539765319426333
PEG ratio: 0.8339457684691911
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): -17567000000
Net cash (USD): -79182000000
Net cash to market cap %: -80.42809029007135
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.105768454063359 (Safe Zone)
Piotroski F-score: 6 (Neutral)
MDXH — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Low)
Market cap (USD): 488990230.4
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MDXH — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 339519477.2
Net income (USD): -46855319.148936175
P/B ratio: 34.26176152098765
Pays dividend: no
Net asset value (USD): -77422340.42553192
Net cash (USD): -100337234.04255319
Net cash to market cap %: -29.552718115034015
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.288357756058179 (Distress Zone)
Piotroski F-score: 2 (Weak)
MDXH — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 202376208.8
Net income (USD): -47888888.88888889
Revenue growth %: 97.85364303149157
Smoothed growth %: 97.85364303149157
P/B ratio: 25.268949489456137
Pays dividend: no
Net asset value (USD): -81172222.22222222
Net cash (USD): -110604444.44444443
Net cash to market cap %: -54.65288884512616
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.6636361158277118 (Distress Zone)
Piotroski F-score: 7 (Neutral)
MDXH — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 121733912.4
Net income (USD): -39655208.333333336
Revenue growth %: 20.26973843545653
Smoothed growth %: 20.26973843545653
P/B ratio: 7.874439451788962
Pays dividend: no
Net asset value (USD): -64246875
Net cash (USD): -99677083.33333333
Net cash to market cap %: -81.88111379005784
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.542828530453333 (Distress Zone)
Piotroski F-score: 4 (Weak)
MDXH — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 183371336.4
Net income (USD): -39434117.64705882
Revenue growth %: 35.2988862926263
Smoothed growth %: 35.2988862926263
Pays dividend: no
Net asset value (USD): -106430588.23529412
Net cash (USD): -154135294.11764708
Net cash to market cap %: -84.05637279177678
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.8116431489154223 (Distress Zone)
Piotroski F-score: 5 (Neutral)
MED.SW — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category:  (confidence: Low)
Market cap (USD): 1780799483.076923
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MED.SW — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 1109357321.7391303
Net income (USD): -6285869.565217391
P/B ratio: 4.292257667834418
Pays dividend: no
Net asset value (USD): 182378260.86956522
Net cash (USD): -75554347.82608695
Net cash to market cap %: -6.810641291630097
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 7.595657058886534 (Safe Zone)
Piotroski F-score: 2 (Weak)
MED.SW — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 1244644800
Net income (USD): 736904.7619047619
Revenue growth %: 27.00578021433052
Smoothed growth %: 27.00578021433052
P/E ratio: 1689.0171760904686
P/B ratio: 4.100665722724045
Pays dividend: no
Net asset value (USD): 226554761.9047619
Net cash (USD): -82588095.23809524
Net cash to market cap %: -6.635475055862945
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 7.522140335227217 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MED.SW — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 782743285.3333333
Net income (USD): 3920000
EPS growth %: 431.9547657512116
Revenue growth %: -1.0206000459106617
Smoothed growth %: 431.9547657512116
P/E ratio: 199.67940952380954
P/B ratio: 2.6125696535457594
PEG ratio: 0.4622692590890796
Pays dividend: no
Net asset value (USD): 241983333.3333333
Net cash (USD): -57365555.55555555
Net cash to market cap %: -7.3287828372908095
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.2636031402896677 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MED.SW — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1358080729.113924
Net income (USD): 11817721.51898734
EPS growth %: 201.4724877292689
Revenue growth %: 36.43513617457479
EPS 2-year CAGR %: 300.4618915583083
Smoothed growth %: 300.4618915583083
P/E ratio: 166.63517853769127
P/B ratio: 3.979297332096044
PEG ratio: 0.5545967166533453
Pays dividend: no
Net asset value (USD): 43611392.40506329
Net cash (USD): -317827848.1012658
Net cash to market cap %: -23.402721302777906
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.9676317102540577 (Grey Zone)
Piotroski F-score: 5 (Neutral)
MEDP — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 9316910439
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
MEDP — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 9273089140.65
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
MEDP — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 8504402161.95
Net income (USD): 114595000
P/E ratio: 18.553170212378376
P/B ratio: 14.326605833048353
Pays dividend: no
Net asset value (USD): -102917000
Net cash (USD): -862324000
Net cash to market cap %: -10.13973685132354
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.016322738532123 (Safe Zone)
Piotroski F-score: 4 (Weak)
MEDP — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 8760352038.300001
Net income (USD): 90260000
P/E ratio: 42.76367205242733
P/B ratio: 50.828553581354335
Pays dividend: no
Net asset value (USD): -523938000
Net cash (USD): -1352992000
Net cash to market cap %: -15.444493487074022
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.2447942715835056 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MEDP — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 14351056534.8
Net income (USD): 111135000
P/E ratio: 45.416173090287664
P/B ratio: 48.872795470659746
Pays dividend: no
Net asset value (USD): -402412000
Net cash (USD): -1174020000
Net cash to market cap %: -8.180721727024828
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.693268524550021 (Safe Zone)
Piotroski F-score: 8 (Strong)
MEDP — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 15676581030.75
Net income (USD): 135133000
P/E ratio: 34.75012586534049
P/B ratio: 34.14848908066508
Pays dividend: no
Net asset value (USD): -236745000
Net cash (USD): -1019352000
Net cash to market cap %: -6.502387210581924
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.276370766630441 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MEDP — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 13143169024
Net income (USD): 123870000
EPS growth %: 8.093721366551769
Revenue growth %: 26.502318420251715
Smoothed growth %: 8.093721366551769
P/E ratio: 30.23866498740554
P/B ratio: 22.921203683868335
PEG ratio: 3.7360644897377226
Pays dividend: no
Net asset value (USD): -97347000
Net cash (USD): -878618000
Net cash to market cap %: -6.684978321404869
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 5.363868231424175 (Safe Zone)
Piotroski F-score: 5 (Neutral)
MEDP — Peter Lynch category analysis (quarterly, as of 2026-06-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 16785511424
Net income (USD): 121362000
EPS growth %: 34.45823177487259
Revenue growth %: 17.24152219999304
Smoothed growth %: 34.45823177487259
P/E ratio: 31.115746180963576
P/B ratio: 34.07020536865494
PEG ratio: 0.9029989229933035
Pays dividend: no
Net asset value (USD): -261645000
Net cash (USD): -1120632000
Net cash to market cap %: -6.676186216153744
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.210831257055881 (Safe Zone)
Piotroski F-score: 7 (Neutral)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category:  (confidence: Low)
Market cap (USD): 962106430.3631152
P/B ratio: 4.924431692295277
Pays dividend: no
Net asset value (USD): 189288342.09268993
Net cash (USD): -145285475.39417106
Net cash to market cap %: -15.100769603975921
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1162994369.1572442
Net income (USD): 5348642.032870963
P/E ratio: 54.35932906006189
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1065062527.7161863
Net income (USD): 6001285.948094458
P/E ratio: 44.368096143392705
P/B ratio: 5.236249266241465
Pays dividend: no
Net asset value (USD): 197529342.9974281
Net cash (USD): -137987608.13654432
Net cash to market cap %: -12.955822268241016
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.52553824139548 (Safe Zone)
Piotroski F-score: 3 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1270975966.534051
Net income (USD): 4956470.8635619
P/E ratio: 77.94338766346378
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1079929445.6945527
Net income (USD): 6439456.388548513
P/E ratio: 47.47807609907653
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 1113109877.7448072
Net income (USD): 6780733.361593896
EPS growth %: 26.774858364455472
Revenue growth %: 8.556883341061223
Smoothed growth %: 26.774858364455472
P/E ratio: 0.4852997903486415
P/B ratio: 5.085099503308231
PEG ratio: 0.01812520476272223
Pays dividend: no
Net asset value (USD): 204114985.16320476
Net cash (USD): -144702310.300975
Net cash to market cap %: -12.999822676459043
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.4239908487158885 (Safe Zone)
Piotroski F-score: 3 (Weak)
MEDPLUS.NS — Peter Lynch category analysis (quarterly, as of 2026-06-30)
Sector: Healthcare | Industry: Pharmaceutical Retailers
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 912837005.7601012
Net income (USD): 3499947.2518198118
EPS growth %: -41.68004520879191
Revenue growth %: 12.358952746057277
Smoothed growth %: -41.68004520879191
P/E ratio: 0.4884704407452368
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
MEG.AX — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Industrial Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 8504957.763975155
P/B ratio: 2.1491211032669666
Pays dividend: no
Net asset value (USD): 4165696.894409938
Net cash (USD): 1250152.7950310558
Net cash to market cap %: 14.699106447375742
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MEGL — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MEGL — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 5201984
Net income (USD): -493232.0924261874
P/B ratio: 0.29723754506859573
Pays dividend: no
Net asset value (USD): 17501100
Net cash (USD): 14639406.16174583
Net cash to market cap %: 281.41966914442315
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.084150951219747 (Safe Zone)
Piotroski F-score: 2 (Weak)
MEGL — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Speculative (confidence: Low)
Market cap (USD): 4795579
Net income (USD): -61947.75928297055
Revenue growth %: 22.846950587934355
Smoothed growth %: 22.846950587934355
P/B ratio: 0.27894592813825875
Pays dividend: no
Net asset value (USD): 17191787.067861717
Net cash (USD): 11321190.268886043
Net cash to market cap %: 236.07556603459236
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.4259721668834215 (Safe Zone)
Piotroski F-score: 8 (Strong)
MEGL — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Speculative (confidence: Low)
Market cap (USD): 2194587
Net income (USD): -609517.0103092784
Revenue growth %: -6.709870729839042
Smoothed growth %: -6.709870729839042
P/B ratio: 0.13146717150692572
Pays dividend: no
Net asset value (USD): 16693041.8814433
Net cash (USD): 15580735.567010311
Net cash to market cap %: 709.9620824788587
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.419300112999125 (Grey Zone)
Piotroski F-score: 3 (Weak)
MEGL — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Speculative (confidence: Low)
Market cap (USD): 5823657
Net income (USD): -1067951.1568123393
Revenue growth %: -10.050410014006909
Smoothed growth %: -10.050410014006909
P/B ratio: 0.3051523666155253
Pays dividend: no
Net asset value (USD): 15582178.020565553
Net cash (USD): 14925224.164524421
Net cash to market cap %: 256.28611308194183
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.612349608610069 (Safe Zone)
Piotroski F-score: 4 (Weak)
MEK.AX — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 134622775.57894737
Net income (USD): -2586626.3157894737
P/B ratio: 9.463251790384515
Pays dividend: no
Net asset value (USD): 14225847.368421052
Net cash (USD): 3925233.834586466
Net cash to market cap %: 2.9157279054052605
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
MEK.AX — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 102901316.96551724
Net income (USD): -2064537.9310344828
P/B ratio: 8.289995366818362
Pays dividend: no
Net asset value (USD): 12412711.034482758
Net cash (USD): -1244151.0344827587
Net cash to market cap %: -1.2090720227610694
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
MEK.AX — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 59287513.74834438
Net income (USD): -658363.5761589404
P/B ratio: 3.522470695734833
Pays dividend: no
Net asset value (USD): 16831229.8013245
Net cash (USD): -1316157.6158940399
Net cash to market cap %: -2.2199575132812748
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 4 (Weak)
MEK.AX — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 59682763.84
Net income (USD): -1961075.3333333333
P/B ratio: 3.2067847206936393
Pays dividend: no
Net asset value (USD): 18611403.333333332
Net cash (USD): -3054162.666666667
Net cash to market cap %: -5.117327801464408
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MEK.AX — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 177487958.16993463
P/E ratio: 9.150326797385622
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
MEL.MC — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Cyclical | Industry: Lodging
Lynch category:  (confidence: Low)
Market cap (USD): 1434524942.9318182
Pays dividend: no
Net cash (USD): 106721590.9090909
Net cash to market cap %: 7.439507513266243
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
MEL.MC — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Cyclical | Industry: Lodging
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1024211711.5106385
Net income (USD): 127790425.5319149
P/E ratio: 8.014776594157654
P/B ratio: 2.159378734596837
Pays dividend: no
Net asset value (USD): 354213829.78723407
Net cash (USD): -3987789361.702128
Net cash to market cap %: -389.3520565021099
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.22673018584340437 (Distress Zone)
Piotroski F-score: 4 (Weak)
MEL.MC — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Cyclical | Industry: Lodging
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1392855011.488889
Net income (USD): 144564444.44444445
EPS growth %: 13.12619379950365
Revenue growth %: 23.436380308356863
Smoothed growth %: 13.12619379950365
P/E ratio: 9.634838060226889
P/B ratio: 2.226007614956665
PEG ratio: 0.734016136543041
Pays dividend: no
Net asset value (USD): 451787777.7777778
Net cash (USD): -4120683333.3333335
Net cash to market cap %: -295.84438432888567
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.43667922860998537 (Distress Zone)
Piotroski F-score: 9 (Strong)
MEL.MC — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Lodging
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1633973146.1666667
Net income (USD): 168792708.33333334
EPS growth %: 16.75949019276294
Revenue growth %: -1.8575463631630662
EPS 2-year CAGR %: 14.928485222236109
Smoothed growth %: 14.928485222236109
P/E ratio: 9.680353863034664
P/B ratio: 1.4661631386785583
PEG ratio: 0.6484485008978468
Pays dividend: no
Net asset value (USD): 676902083.3333334
Net cash (USD): -3475955208.3333335
Net cash to market cap %: -212.7302530331048
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.6999920021287942 (Distress Zone)
Piotroski F-score: 9 (Strong)